System for manipulating nucleic acids
Abstract
The present invention provides an improved system for linking nucleic acids to one another. In particular, the present invention provides techniques for producing DNA product molecules that may be easily and directly ligated to recipient molecules. The product molecules need not be cleaved with restriction enzymes in order to undergo such ligation. In preferred embodiments of the invention, the DNA product molecules are produced through iterative DNA synthesis reactions, so that the product molecules are amplified products. The invention further provides methods for directed ligation of product molecules (i.e., for selective ligation of certain molecules within a collection of molecules), and also for methods of exon shuffling, in which multiple different product molecules are produced in a single ligation reaction. Preferred embodiments of the invention involve ligation of product molecules encoding functional protein domains, particularly domains naturally found in conserved gene families. The inventive DNA manipulation system is readily integrated with other nucleic acid manipulation systems, such as ribozyme-mediated systems, and also is susceptible to automation.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method for introducing sequence changes into a nucleic acid molecule, the method comprising steps of:
contacting the nucleic acid molecule with a first primer containing a first portion that hybridizes with the template, a second portion that includes a residue that renders the primer susceptible to cleavage, and a third portion that contains the sequence changes as compared with the template complement; contacting the nucleic acid molecule with a second primer that hybridizes thereto; extending the first and second primers; and cleaving the first primer at the susceptibility residue so that a double-stranded product molecule having a single-stranded overhang, and having the sequence changes introduced, is produced.
2 . A method for introducing sequence changes into a nucleic acid molecule, the method comprising steps of:
contacting the nucleic acid molecule with a first primer containing a first portion that hybridizes with the template, a second portion that includes at least one terminating residue that does not serve as a template for at least one polymerase, and a third portion that contains the sequence changes as compared with the template complement; extending the first primer to produce a first modified strand; and contacting the first modified strand with a second primer that hydbridizes thereto; extending the second primer with the polymerase, so that a double-stranded product molecule is generating containing a 5′overhang due to failure of the polymerase to template the terminating residue.
3 . The method of claim 1 or claim 2 , wherein the sequence changes are selected from the group consisting of: changes that alter gene product function; changes that adjust for codon bias; changes that introduce at least one restriction site; and combinations thereof.
4 . The method of claim 1 or claim 2 , wherein the template molecule comprises a protein-coding gene, and the sequence changes alter the encoded protein's amino-acid sequence.
5 . The method of claim 1 or claim 2 , wherein the template molecule comprises a protein-coding gene, and the sequence changes do not alter the encoded protein's amino-acid sequence.
6 . The method of claim 1 or claim 2 , wherein the template molecule comprises vector sequence.
7 . The method of claim 1 or claim 2 , wherein the product molecule comprises vector sequence.
8 . The method of claim 1 or claim 2 , further comprises ligating the product molecule with another nucleic acid molecule.
9 . The method of claim 8 , wherein the ligating occurs in vitro.
10 . The method of claim 9 , wherein the ligating occurs in vivo.
11 . The method of claim 1 or claim 2 , further comprising introducing the product molecule into a host cell.
12 . The method of claim 11 , wherein, prior to its introduction into a host cell, the product molecule is ligated with or linked to at least one other nucleic acid molecule.
13 . The method of claim 1 or claim 2 , further comprising isolating the product molecule.
14 . The method of claim 1 or claim 2 , further comprising treating the product molecule to remove template molecules or strands.
15 . The method of claim 14 , wherein the treating comprises digesting methylated nucleic acids.
16 . The method of claim 11 , wherein the product molecule is not treated with ligase enzyme in vitro prior to being introduced into the host cell.
17 . The method of claim 11 , wherein the sequence changes are introduced into a gene that is expressed in the host cell.
18 . The method of claim 17 , wherein the gene encodes an enzyme.
19 . The method of claim 18 , wherein the enzyme catalyzes production or breakdown of a chemical product.
20 . A mutagenized nucleic acid molecule generated by the process of claim 1 or claim 2.Join the waitlist — get patent alerts
Track US2004005673A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.